Pirfenidone is a renal protective drug: Mechanisms, signalling pathways, and preclinical evidence-Reference-Cited by-同舟云学术

Pirfenidone is a renal protective drug: Mechanisms, signalling pathways, and preclinical evidence

Published:2021-11 Issue: Volume:911 Page:174503
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Bai Xue,Nie Ping^ORCID,Lou Yan^ORCID,Zhu Yuexin,Jiang Shan,Li Bing,Luo Ping^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. Pirfenidone is a cardioprotective drug: mechanisms of action and preclinical evidence;Aimo;Pharmacol. Res.,2020

2. Effect of pirfenidone against vanadate-induced kidney fibrosis in rats;Al-Bayati;Biochem. Pharmacol.,2002

3. The experimental agent pirfenidone reduces pro-fibrotic gene expression in a model of tacrolimus-induced nephrotoxicity;Brook;J. Surg. Res.,2005

4. Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats;Chen;PLOS ONE,2013

5. Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats;Chen;Am. J. Physiol. Renal. Physiol.,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming;Pharmacological Research;2024-09

2. Therapeutic approaches and novel antifibrotic agents in renal fibrosis: A comprehensive review;Journal of Biochemical and Molecular Toxicology;2024-08

3. Drug repurposing for glomerular diseases: an underutilized resource;Nature Reviews Nephrology;2024-07-31

4. Hyaluronic acid modified extracellular vesicles targeting hepatic stellate cells to attenuate hepatic fibrosis;European Journal of Pharmaceutical Sciences;2024-07

5. Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease;Antioxidants;2024-06-03